| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/30/2001 | WO2001063294A2 Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| 08/30/2001 | WO2001063284A2 Internal standards and controls for multiplexed assay |
| 08/30/2001 | WO2001062984A2 Detection of human papilloma viruses |
| 08/30/2001 | WO2001062983A1 Improved methods for generating catalytic proteins |
| 08/30/2001 | WO2001062981A1 Platform for the discovery of the bacterial genes involved in rna modification |
| 08/30/2001 | WO2001062980A1 Methods for identifying a protease inhibitor |
| 08/30/2001 | WO2001062976A1 Rapid nucleic acid separation, isolation and purification methods |
| 08/30/2001 | WO2001062975A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 08/30/2001 | WO2001062974A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | WO2001062973A1 Antisense modulation of e2f transcription factor 3 expression |
| 08/30/2001 | WO2001062972A1 Methods for identifying candidate polynucleotide molecules encoding a protease |
| 08/30/2001 | WO2001062971A1 Detection of receptors for orphan ligands by retroviral display |
| 08/30/2001 | WO2001062970A1 Methods and compositions for identifying a protease |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062965A2 Differential expression screening method |
| 08/30/2001 | WO2001062961A1 Ligase/polymerase method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001062960A2 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001062959A2 Endometriosis-related markers and uses thereof |
| 08/30/2001 | WO2001062958A1 Assessment of the functional significance of a nucleotide sequence by subjecting the reading frame data to data processing |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062953A2 Electrochemical method for detecting nucleic acids |
| 08/30/2001 | WO2001062946A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds |
| 08/30/2001 | WO2001062945A1 Methods for generating hypermutable yeast |
| 08/30/2001 | WO2001062944A2 Intergenic and intragenic integration sites for foreign gene expression in recombinant s. gordonii strains |
| 08/30/2001 | WO2001062943A1 Topoisomerase linker-mediated amplification methods |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062941A2 Regulation of human gelatinase b-like enzyme 2 |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062939A1 Process for producing avermectin derivative |
| 08/30/2001 | WO2001062938A2 Variant galactose oxidase, nucleic acid encoding same, and methods of using same |
| 08/30/2001 | WO2001062937A1 Skin infection-related retroviral sequences |
| 08/30/2001 | WO2001062936A2 Bunyaviridal reaper proteins and uses therefor |
| 08/30/2001 | WO2001062935A1 A process for constructing dna based molecular marker for enabling selection of drought and diseases resistant germplasm screening |
| 08/30/2001 | WO2001062934A1 Starch branching enzyme |
| 08/30/2001 | WO2001062933A2 Muteins of interleukin-13 (il-13) |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062931A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 08/30/2001 | WO2001062930A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | WO2001062929A2 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 08/30/2001 | WO2001062928A2 Polypeptides and nucleic acids encoding same |
| 08/30/2001 | WO2001062927A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
| 08/30/2001 | WO2001062926A2 44576, a novel g-protein coupled receptor and uses therefor |
| 08/30/2001 | WO2001062925A2 103p2d6: tissue specific protein highly expressed in various cancers |
| 08/30/2001 | WO2001062924A2 Human g protein-coupled receptors |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062922A2 Polypeptides and corresponding molecules for disease detection and treatment |
| 08/30/2001 | WO2001062921A2 Novel human regulatory protein and polynucleotides encoding the same |
| 08/30/2001 | WO2001062920A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | WO2001062919A1 Modified fluorescent proteins |
| 08/30/2001 | WO2001062918A2 Secretory polypeptides and corresponding polynucleotides |
| 08/30/2001 | WO2001062917A1 Isolated genomic sequences which encode the ny-eso-1 cancer testis tumor antigen and uses thereof |
| 08/30/2001 | WO2001062916A1 Novel armadillo repeat-containing protein alex1 |
| 08/30/2001 | WO2001062915A1 Novel protein and gene encoding the same |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062913A1 Vertebrate globin |
| 08/30/2001 | WO2001062912A2 Method of modulating glycosylation pathways |
| 08/30/2001 | WO2001062911A2 Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
| 08/30/2001 | WO2001062910A1 Immunostimulatory oligonucleotides |
| 08/30/2001 | WO2001062909A1 Immunostimulatory oligonucleotides |
| 08/30/2001 | WO2001062908A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 08/30/2001 | WO2001062907A1 Antibody library |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062904A1 Regulation of human gelatinase b-like enzyme 1 |
| 08/30/2001 | WO2001062902A1 Hybrid cell vaccines |
| 08/30/2001 | WO2001062897A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 08/30/2001 | WO2001062896A2 Xa21-SPECIFIC AVIRULENCE DETERMINANTS FROM XANTHOMONAS ORYZAE PV. ORYZAE |
| 08/30/2001 | WO2001062892A2 Method for ligating nucleic acids and molecular cloning |
| 08/30/2001 | WO2001062890A2 A process for generating genetically modified pearl millet through agrobacterium and biolistic transformation |
| 08/30/2001 | WO2001062889A2 A process for generating cytoplasmic male sterile line in rice and other crops by rna editing |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/30/2001 | WO2001062796A1 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062790A2 Nuclear factor polypeptides and nucleic acids encoding same |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062788A2 Corneodesmosin based test and model for inflammatory disease |
| 08/30/2001 | WO2001062787A1 Diagnosis and treatment of bipolar affective disorder |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062783A1 A novel polypeptide-human split complex 69 and the polynucleotide encoding said polypeptide |
| 08/30/2001 | WO2001062781A2 Homogentisate phytyl transferase |
| 08/30/2001 | WO2001062780A1 Gene expression system based on chimeric receptors |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062773A1 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD |
| 08/30/2001 | WO2001062770A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | WO2001062725A2 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | WO2001062378A2 Microarray fabrication techniques and apparatus |
| 08/30/2001 | WO2001062377A2 Microarray fabrication techniques and apparatus |
| 08/30/2001 | WO2001062288A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | WO2001062286A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062279A1 Method of treatment of anorectal disorders |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062207A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | WO2001062076A1 Production of mammals which produce progeny of a single sex |
| 08/30/2001 | WO2001053474A8 Flavobacterium heparinum expression system |
| 08/30/2001 | WO2001026458A3 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 08/30/2001 | WO2001025421A3 Materials and method for detecting interaction of cftr polypeptides |